Riskpilot← Back to searchSign inGet full accessCompvax A/S
A/SDissolvedCVR 40311378Schæfergårdsvej 19Wholesale of machine tools · NACE 4662Est. 20191 employees
Revenue 2023
DKK 3,6M
-27% vs 2022
EBITDA margin
55.5%
+299% vs 2022
Equity ratio
36.9%
Financial strength
Net profit 2023
DKK 1,6M
+490% vs 2022
| Revenue | DKK 3,6M | -27% |
| EBITDA | DKK 2M | +299% |
| Net profit | DKK 1,6M | +490% |
| Total assets | DKK 8,5M | -10% |
| Equity | DKK 3,2M | +101% |
| Employees | 1 | — |
Legal name
Compvax A/S
CVR number
40311378
Legal form
Aktieselskab
NACE code
4662 · Wholesale of machine tools
Founded
19. februar 2019
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af to medlemmer af bestyrelsen eller af et bestyrelsesmedlem i forening med en direktør.
Address
Schæfergårdsvej 19
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 411 | 5.898 | 6.427 | 5.000 | 3.634 |
| Staff expenses | -0 | -5.758 | -5.657 | -4.494 | -1.617 |
| EBITDA | 411 | 140 | 770 | 505 | 2.017 |
| Depreciation & amort. | -2 | -22 | -28 | -28 | -23 |
| EBIT | 410 | 119 | 742 | 477 | 1.994 |
| Net financials | -74 | -55 | -109 | -133 | 30 |
| Profit before tax | 335 | 64 | 633 | 344 | 2.024 |
| Tax | 75 | 12 | 141 | 76 | 445 |
| Net profit | 260 | 52 | 491 | 268 | 1.579 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 9.942 | 8.330 | 8.993 | 9.456 | 8.548 |
| Equity | 760 | 812 | 1.303 | 1.571 | 3.150 |
| Long-term debt | 0 | 648 | 617 | 630 | 630 |
| Short-term debt | 9.182 | 6.870 | 7.072 | 7.255 | 4.768 |
| Total debt | 9.182 | 7.517 | 7.689 | 7.885 | 5.398 |
EBITDA margin
55.5%
This company
15.8%
Market median
+251% vs market
20192023
Equity ratio
36.9%
This company
38.2%
Market median
+3% vs market
20192023
Return on equity
50.1%
This company
18.4%
Market median
+172% vs market
20192023
Net profit margin
43.5%
This company
8.1%
Market median
+437% vs market
20192023
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20192023
Debt / equity
1.71×
This company
0.62×
Market median
-176% vs market
20192023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-02-19 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SW Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2019 | |
AXFLOW A/S | Company | 100.0% | 100.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Compvax A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Søren Weihrauch | Chief Executive Officer | 0 companies |
| Lars Gösta Andreas Lindahl | Board of Directors | 0 companies |
| Olga Krejci Halkovova | Board of Directors | 0 companies |
| Leif Ole Weiner | Chairman | 0 companies |
| Per Lars Martin Carlson | Board of Directors | 0 companies |
| Johanna Gydingsgård | Board of Directors | 0 companies |